ARCHIVES

Adding Aresenic To Therapy Improves APL Survival

This article is from The Cancer Letter archive.

Vol. 30 No. 7 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Peter Pisters named CEO of University Health Network in Toronto

August 8, 2014

ASCO, ONS Issue Standards For Safe Chemotherapy Administration

October 2, 2009

In Brief: Pasche Named Director of Wake Forest Cancer Center

March 7, 2014

Appropriators Ask What Happens After NIH Budget-Doubling Ends In FY2004.

May 25, 2001

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

August 3, 2001

SWOG Plans Increase in Payments to Centers for Trial Accrual.

May 25, 2007